Form 4: Alignment Healthcare Chief Medical Officer Sells Shares Under 10b5-1 Plan

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold 62,574 shares of common stock at a weighted average price of $12.2027 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Hyong Kim, the Chief Medical Officer of Alignment Healthcare, sold 62,574 shares of the company's common stock on December 5, 2024.
• The sale was executed under a pre-arranged trading plan (Rule 10b5-1) adopted on September 5, 2024.
• The shares were sold at a weighted average price of $12.2027, with individual transactions ranging from $12.10 to $12.50 per share.
• Following the transaction, Kim directly owns 470,496 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction under a pre-arranged plan, which is neither positive nor negative in itself. The sentiment is neutral.

Risks

• Insider selling can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider transactions are a normal part of the market, and this sale by the Chief Medical Officer is not unusual. It is important to note that the sale was conducted under a pre-arranged 10b5-1 trading plan, which is a common practice for corporate insiders to avoid accusations of trading on non-public information.

Comparison to Industry Standards

• Sales by executives are common across the healthcare industry, and the use of 10b5-1 plans is a standard practice to ensure compliance with insider trading regulations.
• Comparable companies often see similar transactions by their executives, and the impact on the stock price is usually minimal unless there are other significant factors at play.

Stakeholder Impact

• The sale may have a minor impact on shareholder sentiment, but it is unlikely to have a significant effect given the pre-planned nature of the transaction.

Key Dates

Keywords

insider trading, stock sale, Rule 10b5-1, Alignment Healthcare, ALHC, Hyong Kim, Chief Medical Officer, share transaction